GNRH1 and neoplasm: To explain the agonistic behavior of GnRH antagonists at the level of tumor cells, Millar and coworkers proposed that these receptors may adopt different conformations according to the cell context in which they are expressed, thus selectively binding to the different GnRH analogs (the “ligand-induce selective signaling” theory) [211].